37858 Federal Register / Vol. 70, No.
125 / Thursday, June 30, 2005 / Notices
holding company by acquiring 100
percent of the outstanding shares of
DeKalb Bank, Crossville, Alabama.
In connection with this application,
Applicant has also filed a notice to
retain 100 percent of the outstanding
shares of Heritage First Bank, Rome,
Georgia, and thereby engage in
operating a federal savings association,
pursuant to section 225.28(b)(4)(ii) of
Regulation Y.
3. Heritage FirstBancshares, Inc.,
Rome, Georgia, to retain its wholly-
owned subsidiary, Heritage First Bank,
a federal savings association, Rome,
Georgia, and thereby engage in
operating a savings association,
pursuant to section 225.28(b)(4)(ii) of
Regulation Y.
B. Federal Reserve Bank of Chicago
(Patrick M. Wilder, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690-1414:
1. FirstBank Corporation, Alma,
Michigan; to acquire 100 percent of the
voting shares of Keystone Financial
Corporation, Kalamazoo, Michigan, and
thereby indirectly acquire Keystone
Community Bank, Kalamazoo,
Michigan.
Board of Governors of the Federal Reserve
System, June 24, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–12897 Filed 6–29–05; 8:45 am]
BILLING CODE 6210–01–S
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisition of Shares of Bank or Bank
Holding Companies
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire a bank or bank
holding company. The factors that are
considered in acting on the notices are
set forth in paragraph 7 of the Act (12
U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the office of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than July 14,
2005.
A. Federal Reserve Bank of
Minneapolis (Jacqueline G. Nicholas,
Community Affairs Officer) 90
Hennepin Avenue, Minneapolis,
Minnesota 55480-0291:
VerDate jul<14>2003 16:26 Jun 29, 2005 Jkt 205001
1. John M. Morrison, Florida
Intangible Trust, Golden Valley,
Minnesota, and Julie Morrison-Arne of
Long Lake, Minnesota, trustee, to
acquire control of Central Bancshares,
Inc., Golden Valley, Minnesota, and
thereby indirectly acquire control of
Central Bank, Stillwater, Minnesota.
Board of Governors of the Federal Reserve
System, June 24, 2005.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 05–12898 Filed 6–29–05; 8:45 am]
BILLING CODE 6210–01–S
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1843(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
form the National Information Center
Web site at http://www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than July 21, 2005.
A. Federal Reserve Bank of Chicago
(Patrick M. Wilder, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414;
1. AztecAmerica Financial Group,
Inc., Berwyn, Illinois; to become a bank
holding company by acquiring 100
PO 00000 Frm 00114 Fmt 4703 Sfmt 4703 E:\FR\FM\30JNN1.SGM
percent of the voting shares of
AztecAmerica Bank (in organization),
Berwyn, Illinois.
B. Federal Reserve Bank of San
Francisco (Tracy Basinger, Director,
Regional and Community Bank Group)
101 Market Street, San Francisco,
California 94105–1579:
1. Community Bancorp, Las Vegas,
Nevada; to acquire 100 percent of the
voting shares of Bank of Commerce,
Henderson, Nevada.
Dated: Board of Governors of the Federal
Reserve System, June 21, 2005.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. 05–12629 Filed 6–29–05; 8:45 am]
BILLING CODE 6210–01–M
GENERAL SERVICES
ADMINISTRATION
[OMB Control No. 3090–0248]
General Services Administration
Acquisition Regulation; Information
Collection; Solicitation Provisions and
Contract Clauses, Placement of Orders
Clause, and Ordering Information
Clause
AGENCY: Office of the Chief Acquisition
Officer, GSA.
ACTION: Notice of request for comments
regarding a renewal to an existing OMB
clearance.
SUMMARY: Under the provisions of the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35), the General Services
Administration will be submitting to the
Office of Management and Budget
(OMB) a request to review and approve
a renewal of a currently approved
information collection requirement
regarding solicitation provisions and
contract clauses, placement of orders
clause, and ordering information clause.
The clearance currently expires on
September 30, 2005.
Public comments are particularly
invited on: Whether this collection of
information is necessary and whether it
will have practical utility; whether our
estimate of the public burden of this
collection of information is accurate and
based on valid assumptions and
methodology; and ways to enhance the
quality, utility, and clarity of the
information to be collected.
DATES: Submit comments on or before:
August 29, 2005.
FOR FURTHER INFORMATION CONTACT:
Linda Nelson, Procurement Analyst,
Contract Policy Division, GSA, at
telephone (202) 501–1900, or via e-mail
to linda.nelson@gsa.gov.
30JNN1
 Federal Register / Vol. 70, No. 125 / Thursday, June 30, 2005 / Notices
ADDRESSES: Submit comments regarding
this burden estimate or any other aspect
of this collection of information,
including suggestions for reducing this
burden, to the Regulatory Secretariat
(VIR), General Services Administration,
Room 4035, 1800 F Street, NW.,
Washington, DC 20405. Please cite OMB
Control No. 3090–0248, Solicitation
provisions and contract clauses,
Placement of Orders clause, and
Ordering Information clause, in all
correspondence.
SUPPLEMENTARY INFORMATION:
A. Purpose
The General Services Administration
(GSA) has various mission
responsibilities related to the
acquisition and provision of Federal
Supply Service’s (FSS’s) Stock, Special
Order, and Schedules Programs. These
mission responsibilities generate
requirements that are realized through
the solicitation and award of various
types of FSS contracts. Individual
solicitations and resulting contracts may
impose unique information collection
and reporting requirements on
contractors, not required by regulation,
but necessary to evaluate particular
program accomplishments and measure
success in meeting program objectives.
B. Annual Reporting Burden
Respondents: 6,493.
Hours Per Response: .25.
Total Burden Hours: 1,623.
OBTAINING COPIES OF
PROPOSALS: Requesters may obtain a
copy of the information collection
documents from the General Services
Administration, Regulatory Secretariat
(VIR), 1800 F Street, NW., Room 4035,
Washington, DC 20405, telephone (202)
208–7312. Please cite OMB Control No.
3090–0248, Solicitation provisions and
contract clauses, Placement of Orders
clause, and Ordering Information
clause, in all correspondence.
Dated: June 24, 2005.
Julia Wise,
Director, Contract Policy Division.
[FR Doc. 05–12899 Filed 6–29–05; 8:45 am]
BILLING CODE 6820–61–S
VerDate jul<14>2003 16:26 Jun 29, 2005 Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004N–0515]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Medical Device Labeling Regulations
AGENCY: Food and Drug Administration,
HHS.
ACTION: Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Medical Device Labeling Regulations’’
has been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Peggy Robbins, Office of Management
Programs (HFA–250), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857,301–827–1223.
SUPPLEMENTARY INFORMATION: In the
Federal Register of April 1, 2005 (70 FR
16824), the agency announced that the
proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0485. The
approval expires on June 30, 2008. A
copy of the supporting statement for this
information collection is available on
the Internet at http://www.fda.gov/
ohrms/dockets.
Dated: June 23, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05–12907 Filed 6–29–05; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004N–0558]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Evaluating the
Safety of Antimicrobial New Animal
Drugs With Regard to Their
Microbiological Effects on Bacteria of
Human Health Concerns
AGENCY: Food and Drug Administration,
HHS.
PO 00000 Frm 00115 Fmt 4703 Sfmt 4703 E:\FR\FM\30JNN1.SGM
37859
ACTION: Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that the proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by August 1,
2005.
ADDRESSES: OMB is still experiencing
significant delays in the regular mail,
including first class and express mail,
and messenger deliveries are not being
accepted. To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: Fumie Yokota, Desk Officer
for FDA, FAX: 202–395–6974.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Office of Management
Programs (HFA–250), Food and Drug
Administration, 5600 Fishers Lane, rm.
4B–41, Rockville, MD 20857, 301–827–
1472.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Evaluating the Safety of Antimicrobial
New Animal Drugs with Regard to
Their Microbiological Effects on
Bacteria of Human Health Concern
(OMB Control Number 0910–0522)
In the Federal Register of January 6,
2005 (70 FR 1253), FDA published a 60-
day notice requesting public comment
on the information collection
provisions. No comments were received
on this information collection.
Description: This guidance discusses
an approach for assessing the safety of
antimicrobial new animal drugs with
regard to their microbiological effects on
bacteria of human health concern. In
particular, the guidance describes
methodology that sponsors of
antimicrobial new animal drug
applications for food-producing animals
may use to complete a qualitative
antimicrobial resistance risk assessment.
This risk assessment should be
submitted to FDA for the purposes of
evaluating the safety of the new animal
drug to human health. The guidance
document outlines a process for
integrating relevant information into an
overall estimate of risk and discusses
possible risk management strategies.
Table 1 of this document represents
the estimated burden of meeting the
reporting requirements. The burden
30JNN1